| Disease ID | Disease name | Reference |
|---|
| MESH:D000013 |
Congenital Abnormalities |
PMID:11010742 |
| MESH:D000140 |
Acidosis, Lactic |
PMID:11214134; PMID:15040545 |
| MESH:D000740 |
Anemia |
PMID:10770762; PMID:11454181; PMID:11569724; PMID:11781627; PMID:11807019; PMID:11981781; PMID:12197841; PMID:12197842; PMID:12713065; PMID:14568602; PMID:14582000; PMID:14586905; PMID:14738562; PMID:15067629; PMID:15081101; PMID:15131791; PMID:15219067; PMID:15220675; PMID:15232364; PMID:15488656; PMID:15597026; PMID:15660393; PMID:15667486; PMID:15778976; PMID:15996025; PMID:16002945; PMID:16010160; PMID:16010180; PMID:16198661; PMID:16234051; PMID:16557544; PMID:16597599; PMID:16637862; PMID:1683355; PMID:16872308; PMID:16970600; PMID:16980747; PMID:17001400; PMID:17032408; PMID:17058596; PMID:17107736; PMID:17118125; PMID:17133490; PMID:17168855; PMID:17204208; PMID:17249181; PMID:17263626; PMID:17311621; PMID:17381375; PMID:17397412; PMID:17409018; PMID:17470380; PMID:17474827; PMID:17559739; PMID:17714473; PMID:18205802; PMID:18240862; PMID:18265628; PMID:18756437; PMID:18796095; PMID:18855993; PMID:19565241; PMID:19821346; PMID:19950239; PMID:20009130; PMID:20377423; PMID:20637204; PMID:20710050; PMID:21304937; PMID:2445283; PMID:2546248; PMID:8752565; PMID:9011471; PMID:9278222; PMID:9875657 |
| MESH:D000743 |
Anemia, Hemolytic |
PMID:10733558; PMID:11010742; PMID:11330434; PMID:11451176; PMID:11705128; PMID:12736713; PMID:12897097; PMID:14768501; PMID:15117320; PMID:15293138; PMID:15468613; PMID:15482540; PMID:15580403; PMID:15622486; PMID:15754628; PMID:15828854; PMID:16340643; PMID:16381245; PMID:16629641; PMID:16633111; PMID:17048050; PMID:17299014; PMID:18432160; PMID:19628158; PMID:20303990; PMID:20446436; PMID:20547162 |
| MESH:D000744 |
Anemia, Hemolytic, Autoimmune |
PMID:18200424; PMID:19337648 |
| MESH:D000860 |
Hypoxia |
PMID:16002945 |
| MESH:D001008 |
Anxiety Disorders |
PMID:12297606; PMID:17988237 |
| MESH:D001157 |
Arterial Occlusive Diseases |
PMID:15385825 |
| MESH:D001342 |
Autonomic Nervous System Diseases |
PMID:19047844 |
| MESH:D001523 |
Mental Disorders |
PMID:9278222 |
| MESH:D001714 |
Bipolar Disorder |
PMID:14992966; PMID:18585548 |
| MESH:D001763 |
Blepharoptosis |
PMID:16020909; PMID:19581773 |
| MESH:D001919 |
Bradycardia |
PMID:17381375 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
PMID:16462543 |
| MESH:D002386 |
Cataract |
PMID:15316341 |
| MESH:D002543 |
Cerebral Hemorrhage |
PMID:16679707 |
| MESH:D002561 |
Cerebrovascular Disorders |
PMID:18852671 |
| MESH:D003072 |
Cognition Disorders |
PMID:15637534; PMID:19441669 |
| MESH:D003117 |
Color Vision Defects |
PMID:15316341 |
| MESH:D003371 |
Cough |
PMID:9278222 |
| MESH:D003449 |
Cryoglobulinemia |
PMID:17548949 |
| MESH:D003639 |
Hearing Loss, Sudden |
PMID:15128353; PMID:17879419 |
| MESH:D003693 |
Delirium |
PMID:20838237 |
| MESH:D003865 |
Depressive Disorder, Major |
PMID:16096520; PMID:17845538; PMID:20838237 |
| MESH:D003866 |
Depressive Disorder |
PMID:12297606; PMID:15669887; PMID:16633105; PMID:17058596; PMID:17068951; PMID:17292481; PMID:17451562; PMID:17465000; PMID:17474827; PMID:17591516; PMID:17668880; PMID:17988237; PMID:18258414; PMID:18458677; PMID:18702333; PMID:18721241; PMID:19573480; PMID:19691667; PMID:19789525 |
| MESH:D004172 |
Diplopia |
PMID:16020909 |
| MESH:D004342 |
Drug Hypersensitivity |
PMID:10770762 |
| MESH:D005221 |
Fatigue |
PMID:18258414; PMID:18458677 |
| MESH:D006261 |
Headache |
PMID:15951019 |
| MESH:D006312 |
Hearing Loss, Bilateral |
PMID:19047844 |
| MESH:D006319 |
Hearing Loss, Sensorineural |
PMID:16149154; PMID:19047844 |
| MESH:D006456 |
Hemoglobinuria |
PMID:12642748 |
| MESH:D006461 |
Hemolysis |
PMID:1505907; PMID:15778976; PMID:15865084; PMID:8914004 |
| MESH:D006526 |
Hepatitis C |
PMID:16182838 |
| MESH:D006973 |
Hypertension |
PMID:19047844 |
| MESH:D006980 |
Hyperthyroidism |
PMID:18097301 |
| MESH:D007024 |
Hypotension, Orthostatic |
PMID:19047844 |
| MESH:D007037 |
Hypothyroidism |
PMID:16702862 |
| MESH:D007172 |
Erectile Dysfunction |
PMID:18778198 |
| MESH:D007249 |
Inflammation |
PMID:10770762 |
| MESH:D007511 |
Ischemia |
PMID:16169782 |
| MESH:D007970 |
Leukopenia |
PMID:10770762 |
| MESH:D008103 |
Liver Cirrhosis |
PMID:15778976 |
| MESH:D008275 |
Magnesium Deficiency |
PMID:17381375 |
| MESH:D008580 |
Meningism |
PMID:15951019 |
| MESH:D008881 |
Migraine Disorders |
PMID:12763386 |
| MESH:D009135 |
Muscular Diseases |
PMID:14996354 |
| MESH:D009157 |
Myasthenia Gravis |
PMID:19581773 |
| MESH:D009336 |
Necrosis |
PMID:19430526 |
| MESH:D009404 |
Nephrotic Syndrome |
PMID:12080234; PMID:17987400 |
| MESH:D009503 |
Neutropenia |
PMID:15081101; PMID:15597026; PMID:17001400; PMID:17474827; PMID:18240862; PMID:18756437; PMID:18855993; PMID:19565241 |
| MESH:D009901 |
Optic Nerve Diseases |
PMID:17878818 |
| MESH:D010195 |
Pancreatitis |
PMID:11214134; PMID:15040545 |
| MESH:D010211 |
Papilledema |
PMID:15459850 |
| MESH:D010243 |
Paralysis |
PMID:18097301 |
| MESH:D010302 |
Parkinson Disease, Secondary |
PMID:18549943 |
| MESH:D010900 |
Pituitary Diseases |
PMID:16702862 |
| MESH:D011605 |
Psychoses, Substance-Induced |
PMID:12954918 |
| MESH:D011618 |
Psychotic Disorders |
PMID:17845538; PMID:20838237 |
| MESH:D012163 |
Retinal Detachment |
PMID:15951019; PMID:20177954 |
| MESH:D012164 |
Retinal Diseases |
PMID:12578794; PMID:15771758; PMID:17878818 |
| MESH:D012170 |
Retinal Vein Occlusion |
PMID:16937480; PMID:17589934 |
| MESH:D012393 |
Rosacea |
PMID:14558405; PMID:16710591 |
| MESH:D012563 |
Schizophrenia, Paranoid |
PMID:17511042 |
| MESH:D012735 |
Sexual Dysfunction, Physiological |
PMID:19527724 |
| MESH:D013001 |
Somatoform Disorders |
PMID:12297606 |
| MESH:D013262 |
Stevens-Johnson Syndrome |
PMID:25811541 |
| MESH:D013575 |
Syncope |
PMID:12197842 |
| MESH:D013921 |
Thrombocytopenia |
PMID:15081101; PMID:15597026; PMID:17001400; PMID:18756437; PMID:19565241 |
| MESH:D013966 |
Thyroiditis |
PMID:17249181; PMID:17548949 |
| MESH:D014012 |
Tinnitus |
PMID:15128353; PMID:15951019; PMID:19047844; PMID:19783887 |
| MESH:D014607 |
Uveomeningoencephalitic Syndrome |
PMID:14633182; PMID:15951019; PMID:17589934; PMID:20172621; PMID:20177954 |
| MESH:D014657 |
Vasculitis |
PMID:16169782; PMID:17898559 |
| MESH:D014717 |
Vertigo |
PMID:19047844 |
| MESH:D014839 |
Vomiting |
PMID:9278222 |
| MESH:D015835 |
Ocular Motility Disorders |
PMID:19581773 |
| MESH:D015840 |
Oculomotor Nerve Diseases |
PMID:16020909 |
| MESH:D016584 |
Panic Disorder |
PMID:17845538 |
| MESH:D017091 |
Colitis, Ischemic |
PMID:18223489 |
| MESH:D017093 |
Liver Failure |
PMID:16288408 |
| MESH:D017202 |
Myocardial Ischemia |
PMID:17913610 |
| MESH:D017565 |
Sarcoidosis, Pulmonary |
PMID:15316444 |
| MESH:D018366 |
Vasculitis, Leukocytoclastic, Cutaneous |
PMID:18187830 |
| MESH:D018917 |
Optic Neuropathy, Ischemic |
PMID:15459850; PMID:15980766; PMID:17589934; PMID:19201118 |
| MESH:D019964 |
Mood Disorders |
PMID:17014581 |
| MESH:D020246 |
Venous Thrombosis |
PMID:17287904 |
| MESH:D020330 |
Bell Palsy |
PMID:19653353 |
| MESH:D026681 |
Vitamin B 6 Deficiency |
PMID:19042060 |
| MESH:D028361 |
Mitochondrial Diseases |
PMID:11214134 |
| MESH:D034321 |
Hyperamylasemia |
PMID:15040545 |
| MESH:D046088 |
Hearing Loss, Unilateral |
PMID:16149154; PMID:19783887 |
| MESH:D051437 |
Renal Insufficiency |
PMID:22166485 |
| MESH:D053040 |
Nephrolithiasis |
PMID:11330434 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:11214134; PMID:22166485 |
| MESH:D057049 |
Thrombotic Microangiopathies |
PMID:18852671 |
| MESH:D058186 |
Acute Kidney Injury |
PMID:15252182 |
| MESH:D058437 |
Hypertensive Retinopathy |
PMID:17589934 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.